Approvals/TGA/MOMETASONE GXP AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle

Approved

STANDARD

MOMETASONE GXP AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5a7cb960265bb01c
Product Name: MOMETASONE GXP AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle
Artg Id: 233576
Artg Name: MOMETASONE GXP AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2016-01-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

5a7cb960265bb01c

Type

Standard